Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олена Валентинівна Максакова, Елена Валентиновна Максакова, Валерія Володимирівна Корнієнко, Валерия Владимировна КорниенкоfiledCriticalОлена Валентинівна Максакова
Priority to UA99020704ApriorityCriticalpatent/UA33293A/en
Publication of UA33293ApublicationCriticalpatent/UA33293A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
The method relates to the medicine, namely to the ophthalmology. The major inventive objective consists in selecting the drug, which provides for high treatment efficacy due to the increase of the reparative activity of the cornea.
UA99020704A1999-02-091999-02-09Method for treating injuries of cornea
UA33293A
(en)
Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders